2
Measuring maternal, foetal and neonatal mortality: Challenges and solutions

https://doi.org/10.1016/j.bpobgyn.2016.05.006Get rights and content

Highlights

  • Levels and causes of mortality in mothers and babies are intrinsically linked.

  • Measuring levels, trends and causes of maternal, neonatal and foetal mortality are interventions and track their success.

  • There are standard definitions and indicators of measuring mortality in pregnant and post-partum women and their babies.

  • Measurement challenges exist, awareness and attention to these would improve the measurement for these outcomes.

Levels and causes of mortality in mothers and babies are intrinsically linked, occurring at the same time and often to the same mother–baby dyad, although mortality rates are substantially higher in babies. Measuring levels, trends and causes of maternal, neonatal and foetal mortality are important for understanding priority areas for interventions and tracking the success of interventions at the global, national, regional and local level. However, there are many measurement challenges.

This paper provides an overview of the definitions and indicators for measuring mortality in pregnant and post-partum women (maternal and pregnancy-related mortality) and their babies (foetal and neonatal mortality). We then discuss current issues in the measurement of the levels and causes of maternal, foetal and neonatal mortality, and present options for improving measurement of these outcomes. Finally, we illustrate some important uses of mortality data, including for the development of models to estimate mortality rates at the global and national level and for audits.

Introduction

Monitoring levels of maternal mortality has been a priority on the global health agenda. Millennium development goal (MDG) 5 aimed to reduce the maternal mortality ratio (MMR) by 75% between 1990 and 2015. However, measuring progress over this time period was challenging, primarily because of the scarcity of empirical data. Global tracking relied instead on modelled estimates to monitor the success [1]. These estimates suggested that maternal mortality decreased by 44% worldwide in the MDG era [2]. Similar challenges were faced in tracking foetal and neonatal mortality. Neonatal deaths were not explicitly mentioned in MDG 4, which sought to reduce under-5 child mortality by two-thirds, but they were increasingly recognised as comprising almost half of child mortality globally and progressing more slowly. Neonatal mortality was estimated to have decreased by 47% worldwide during this period [3]. Stillbirths (late foetal deaths) were excluded from the MDG targets, and consequently received less attention, although the major associated burden has been quantified more recently [4]. At the end of the MDG era, the number of deaths, albeit based on modelled estimates, remains unacceptably high: 303,000 maternal deaths [2], 2.6 million stillbirths (late foetal deaths) [5] and 2.7 million neonatal deaths [3].

Measuring the levels and trends of maternal, neonatal and foetal mortality is important for quantifying disease burden, understanding risk factors and determinants, identifying priority areas for interventions, programmes and policies, and evaluating the success of interventions at the global, national, regional and local level [6], [7]. Knowing the biomedical causes of mortality in pregnant or recently delivered women, or in their babies, is essential to direct interventions to prevent such deaths. Unfortunately, there are many challenges to measurement, but there are also numerous potential options and solutions.

This paper provides an overview of current issues and options in measuring the levels and causes of maternal, foetal and neonatal mortality. We define these deaths and associated indicators, and then focus on the measurement methods, challenges and solutions, and where possible, present potential opportunities to improve measurement of maternal, neonatal and foetal deaths.

Section snippets

Definitions

To compare maternal, foetal and neonatal mortality across populations or over time requires standardised definitions for each outcome. These definitions were included in the 10th revision of the International Classification of Diseases (ICD-10) [8], as summarised in Table 1 and described below. Various dimensions of these definitions require an ability to assess pregnancy status of women, the timing of death in relation to delivery, gestational age (or alternatively birth weight or birth

Indicators

Counting numbers of maternal, foetal and neonatal deaths can identify countries, regions or subgroups with the largest numeric burden, but often we are also interested in knowing where the risk of such deaths is highest. For example, due to its large population, India has a much greater number of maternal deaths than Sierra Leone, yet the risk of a woman in India dying of maternal causes is much lower than in Sierra Leone [2]. Identifying the risk faced by individual women or babies requires

Current issues in measuring mortality

Despite the existence of definitions and indicators, measuring mortality can be problematic. First, deaths need to be identified, and then categorised and counted. Deaths may be misclassified because aspects of their definitions (including pregnancy/post-partum status, incidental/accidental cause of death, gestational age, survival status at the start of labour and at delivery and day of death post partum) are difficult to recognise, determine, capture or remember. They can also be

Using and interpreting mortality data

Maternal, foetal and neonatal mortality data are used for numerous purposes including examining the burden of mortality and trends in this over time, for identification of risk factors for mortality and for exploring effects of mortality on other outcomes (e.g., effect of a foetal death on maternal mental health or effect of maternal death on infant survival). It can be useful to adopt a life course perspective on health problems; for example, the effect of maternal health on long-term outcomes

Conclusion

Accurate and timely measurement is important to achieve change and inhibit preventable maternal, neonatal and foetal mortality. However, as we have illustrated in this paper, there are numerous obstacles to achieving this goal, particularly in high-burden settings. These challenges range from conceptual difficulties in the definitions of maternal and foetal mortality, to challenges faced in data collection systems making it impossible to count each birth and death, to problems of intentional or

Conflict of interest

The authors declare that they have no conflict of interest.

References (73)

  • R.E. Dorrington et al.

    Acknowledging uncertainty about maternal mortality estimates

    Bull World Health Organ

    (2016 Feb 1)
  • L. Alkema et al.

    Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group

    Lancet

    (2015)
  • UN Inter-agency Group for Child Mortality Estimation (UN-IGME)

    Levels and trends in child mortality

    (2015)
  • J.F. Froen et al.

    Stillbirths: progress and unfinished business

    Lancet

    (2016)
  • H. Blencowe et al.

    National, regional and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis

    Lancet Global Health

    (2016)
  • S. Gabrysch et al.

    Tracking progress towards safe motherhood: meeting the benchmark yet missing the goal? An appeal for better use of health-system output indicators with evidence from Zambia and Sri Lanka

    Trop Med Int Health

    (2011)
  • S. Hodgins

    Achieving better maternal and newborn outcomes: coherent strategy and pragmatic, tailored implementation

    Glob Health Sci Pract

    (2013)
  • World Health Organization

    International classification of diseases 10th revision (ICD-10)

    (2010)
  • M. Garenne et al.

    Protective effect of pregnancy in rural South Africa: questioning the concept of “indirect cause” of maternal death

    PLoS One

    (2013)
  • World Health Organization

    The WHO application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: ICD-MM

    (2012)
  • C. Ronsmans et al.

    Adolescence and risk of violent death during pregnancy in Matlab, Bangladesh

    Lancet

    (1999)
  • L. Hoj et al.

    Maternal mortality: only 42 days?

    BJOG

    (2003)
  • C.J. Berg et al.

    Pregnancy-related mortality in the United States, 1998 to 2005

    Obstet Gynecol

    (2010)
  • L.C. Chen et al.

    Maternal mortality in rural Bangladesh

    Stud Fam Plann

    (1974)
  • K.T. Storeng et al.

    Mortality after near-miss obstetric complications in Burkina Faso: medical, social and health-care factors

    Bull World Health Organ

    (2012)
  • V. Flenady et al.

    Stillbirth: recall to action in high-income countries

    Lancet

    (2016 Feb 13)
  • J.E. Lawn et al.

    Stillbirths: Where? When? Why? How to make the data count?

    Lancet

    (2011)
  • H. Blencowe et al.

    Born too soon: the global epidemiology of 15 million preterm births

    Reprod Health

    (2013)
  • L. Geerts et al.

    A comparison of pregnancy dating methods commonly used in South Africa: a prospective study

    S Afr Med J = Suid-Afrikaanse tydskrif vir geneeskunde

    (2013)
  • C.D. Lynch et al.

    The research implications of the selection of a gestational age estimation method

    Paediatr Perinat Epidemiol

    (2007)
  • K.J. Gold et al.

    Assessment of “fresh” versus “macerated” as accurate markers of time since intrauterine fetal demise in low-income countries

    Int J Gynaecol Obstet

    (2014)
  • J. Lawn et al.

    No cry at birth: global estimates of intrapartum stillbirths and intrapartum-related neonatal deaths

    Bull World Health Organ

    (2005)
  • M. de Swiet

    Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom

    Am J Obstet Gynecol

    (2000)
  • J. Wilmoth

    The lifetime risk of maternal mortality: concept and measurement

    Bull World Health Organ

    (2009)
  • V. Fauveau

    New indicator of quality of emergency obstetric and newborn care

    Lancet

    (2007)
  • R.L. Goldenberg et al.

    A multi-country study of the “intrapartum stillbirth and early neonatal death indicator” in hospitals in low-resource settings

    Int J Gynaecol Obstet

    (2013)
  • S.A. Myers et al.

    Fetal, neonatal and infant death and their relationship to best gestational age for delivery at term: is 39 weeks best for everyone?

    J Perinatol

    (2014)
  • P.L. Yudkin et al.

    Risk of unexplained stillbirth at different gestational ages

    Lancet

    (1987)
  • A. Mandujano et al.

    The risk of fetal death: current concepts of best gestational age for delivery

    Am J Obstet Gynecol

    (2013)
  • A.P. MacKay et al.

    The check box: determining pregnancy status to improve maternal mortality surveillance

    Am J Prev Med

    (2000)
  • P. Setel et al.

    Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics

    Bull World Health Organ

    (2005)
  • C. AbouZahr et al.

    Towards universal civil registration and vital statistics systems: the time is now

    Lancet

    (2015)
  • C. AbouZahr et al.

    Civil registration and vital statistics: progress in the data revolution for counting and accountability

    Lancet

    (2015)
  • L. Mikkelsen et al.

    A global assessment of civil registration and vital statistics systems: monitoring data quality and progress

    Lancet

    (2015)
  • J.E. Lawn et al.

    Stillbirths: rates, risk factors, and acceleration towards 2030

    Lancet

    (2016)
  • R.A. Haws et al.

    “These are not good things for other people to know”: how rural Tanzanian women's experiences of pregnancy loss and early neonatal death may impact survey data quality

    Soc Sci Med (1982)

    (2010)
  • Cited by (0)

    View full text